Back to GetFilings.com




 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

(Mark One)

 

 

x

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended September 30, 2003

 

 

or

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                to              

Commission file number 000-32837

United Surgical Partners International, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of incorporation or organization)

 

75-2749762
(IRS Employer Identification Number)

15305 Dallas Parkway, Suite 1600
Addison, Texas
(Address of principal executive offices)

 


75001
(Zip Code)

 

(972) 713-3500

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x  No o

At November 5, 2003 there were 27,422,093 shares of Common Stock outstanding.

 



UNITED SURGICAL PARTNERS INTERNATIONAL, INC. AND SUBSIDIARIES

INDEX

PART I.

 

Financial Information

 

 

 

 

 

Item 1.

 

Financial Statements (unaudited)

 

3

 

 

 

 

 

Consolidated Balance Sheets as of September 30, 2003 and December 31,
2002

 

3

 

 

 

 

 

Consolidated Statements of Income for the three months and nine months ended September 30, 2003 and 2002

 

4

 

 

 

 

 

Consolidated Statements of Comprehensive Income for the three months and nine months ended September 30, 2003 and 2002

 

5

 

 

 

 

 

Consolidated Statements of Cash Flows for the nine months ended September 30, 2003 and 2002

 

6

 

 

 

 

 

Notes to Consolidated Financial Statements

 

7

 

 

 

Item 2. 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

19

 

 

 

Item 3. 

 

Quantitative and Qualitative Disclosures About Market Risk

 

29

 

 

 

Item 4. 

 

Controls and Procedures

 

29

 

PART II.

 

Other Information

 

 

 

 

 

Item 1. 

 

Legal Proceedings

 

30

 

 

 

Item 6. 

 

Exhibits and Reports on Form 8-K

 

30

 

Signatures

 

32

 

 

Note: Items 2, 3, 4 and 5 of Part II are omitted because they are not applicable.

2



PART I.   FINANCIAL INFORMATION

ITEM 1.   Financial Statements

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
AND SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited—in thousands, except per share amounts)

 

 

September 30,
2003

 

December 31,
2002

 

Assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

$

45,390

 

 

 

$

47,571

 

 

Patient receivables, net of allowance for doubtful accounts of $8,015 and $7,154, respectively

 

 

48,467

 

 

 

39,176

 

 

Other receivables

 

 

11,049

 

 

 

34,735

 

 

Inventories of supplies

 

 

8,210

 

 

 

7,756

 

 

Deferred tax asset, net

 

 

5,732

 

 

 

5,657

 

 

Prepaids and other current assets

 

 

8,352

 

 

 

7,001

 

 

Total current assets

 

 

127,200

 

 

 

141,896

 

 

Property and equipment, net

 

 

326,778

 

 

 

270,387

 

 

Investments in affiliates

 

 

31,440

 

 

 

18,696

 

 

Intangible assets, net

 

 

311,804

 

 

 

287,584

 

 

Other assets

 

 

20,731

 

 

 

8,722

 

 

Total assets

 

 

$

817,953

 

 

 

$

727,285

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

$

29,743

 

 

 

$

25,989

 

 

Accrued salaries and benefits

 

 

19,676

 

 

 

20,322

 

 

Due to affiliates

 

 

4,382

 

 

 

6,890

 

 

Accrued interest

 

 

5,419

 

 

 

1,650

 

 

Current portion of long-term debt

 

 

14,288

 

 

 

13,132

 

 

Other accrued expenses

 

 

25,503

 

 

 

22,501

 

 

Total current liabilities

 

 

99,011

 

 

 

90,484

 

 

Long-term debt, less current portion

 

 

285,223

 

 

 

263,571

 

 

Other long-term liabilities

 

 

8,443

 

 

 

4,532

 

 

Deferred tax liability, net

 

 

28,154

 

 

 

19,577

 

 

Total liabilities

 

 

420,831

 

 

 

378,164

 

 

Minority interests

 

 

36,507

 

 

 

26,860

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

Common stock:

 

 

 

 

 

 

 

 

 

Other, $0.01 par value; 200,000 shares authorized; 27,526 and 27,306 shares issued at September 30, 2003 and December 31, 2002, respectively

 

 

275

 

 

 

273

 

 

Additional paid-in capital

 

 

325,411

 

 

 

320,750